Prescription of antibiotic agents in Swedish intensive care units is empiric and precise

References

• Gruson D, Hilbert G, Vargas F, Valentino R, Bebear C, Allery A, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am J Respir Crit Care Med 2000; 162: 837–43
   PubMed Web of Science ®Google Scholar
• Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001; 48: 161–76
   PubMed Web of Science ®Google Scholar
• Erlandsson CM, Hanberger H, Eliasson I, Hoffmann M, Isaksson B, Lindgren S, et al. Surveillance of antibiotic resistance in ICUs in south-eastern Sweden. ICU Study Group of the South East of Sweden. Acta Anaesthesiol Scand 1999; 43: 815–20
   PubMedGoogle Scholar
• Kiivet RA, Dahl ML, Llerena A, Maimets M, Wettermark B, Berecz R. Antibiotic use in 3 European university hospitals. Scand J Infect Dis 1998; 30: 277–80
   PubMedGoogle Scholar
• Lemmen SW, Hafner H, Kotterik S, Lutticken R, Topper R. Influence of an infectious disease service on antibiotic prescription behaviour and selection of multi-resistant pathogens. Infection 2000; 28: 384–7
   PubMed Web of Science ®Google Scholar
• Naaber P, Koljalg S, Maimets M. Antibiotic usage and resistance trends in Estonian university hospitals. Int J Antimicrob Agents 2000; 16: 309–15
   PubMed Web of Science ®Google Scholar
• Petersen IS, Hesselbjerg L, Jorgensen L, Renstrup J, Barnung S, Schierbeck J, et al. High antibiotic consumption in Danish intensive care units?. APMIS 1999; 107: 989–96
   PubMedGoogle Scholar
• Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000; 56: 97–101
   PubMed Web of Science ®Google Scholar
• Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross-section of Swedish intensive care units. Acta Anaesthesiol Scand 2002; 46: 1075–81
   PubMedGoogle Scholar
• Nguyen HB, Rivers EP, Havstad S, Knoblich B, Ressler JA, Muzzin AM, et al. Critical care in the emergency department: a physiological assessment and outcome evaluation. Acad Emerg Med 2000; 7: 1354–61
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Kollef MH, Hall JB. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 2004; 38: 1141–9
   PubMed Web of Science ®Google Scholar
• Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J 2001; 31: 97–103
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Mascini EM. The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med 2003; 29: 1–2
   PubMed Web of Science ®Google Scholar
• Struelens MJ, Byl B, Vincent JL. Antibiotic policy: a tool for controlling resistance of hospital pathogens. Clin Microbiol Infect 1999; (5 Suppl1): S19–24
   Google Scholar
• Gustafsson I, Sjolund M, Torell E, Johannesson M, Engstrand L, Cars O, et al. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother 2003; 52: 645–50
   PubMed Web of Science ®Google Scholar
• Grundmann H, Hori S, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002; 185: 481–8
   PubMed Web of Science ®Google Scholar
• Maxwell M, Heaney D, Howie JG, Noble S. General practice fundholding: observations on prescribing patterns and costs using the defined daily dose method. Br Med J 1993; 307: 1190–4
   PubMed Web of Science ®Google Scholar
• Bergman U, Christenson I, Jansson B, Wiholm BE. Auditing hospital drug utilization by means of defined daily doses per bed-d. A methodological study. Eur J Clin Pharmacol 1980; 17: 183–7
   PubMedGoogle Scholar
• Hanberger H, Erlandsson M, Burman LG, Cars O, Gill H, Lindgren S, et al. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance programme using TA90 as a novel index of susceptibility. Scand J Infect Dis 2004; 36: 24–30
   PubMed Web of Science ®Google Scholar
• Olsson-Liljequist B, Larsson P, Walder M, Miorner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl 1997; 105: 13–23
   PubMedGoogle Scholar
• Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, et al. Indications for antibiotic use in ICU patients: a 1-y prospective surveillance. J Antimicrob Chemother 1997; 39: 527–35
   PubMed Web of Science ®Google Scholar
• Capella D. Descriptive tools and analysis. WHO Reg Publ Eur Ser 1993; 45: 55–78
   PubMedGoogle Scholar
• Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245–52
   PubMed Web of Science ®Google Scholar
• Fischer JE, Ramser M, Fanconi S. Use of antibiotics in paediatric intensive care and potential savings. Intensive Care Med 2000; 26: 959–66
   PubMed Web of Science ®Google Scholar
• Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113: 412–20
   PubMed Web of Science ®Google Scholar
• Kollef MH. Improving outcomes in the ICU setting: are we effectively using all of the information that is potentially available to us?. Chest 1999; 115: 1490–2
   PubMedGoogle Scholar
• Zaidi M, Sifuentes-Osornio J, Rolon AL, Vazquez G, Rosado R, Sanchez M, et al. Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch Med Res 2002; 33: 290–4
   PubMedGoogle Scholar
• Schurink CA, Hoitsma M, Rozenberg-Arska M, Joore JC, Hoepelman IM, Bonten MJ. Do cultures contribute to optimization of antibiotic therapy in the intensive care unit?. Int J Antimicrob Agents 2004; 23: 325–31
   PubMed Web of Science ®Google Scholar
• Diaz E, Rello J. Top ten list in antibiotic policy in the ICU. Chest 2002; 122: 712–4
   PubMedGoogle Scholar
• Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF, Jr, et al. A computer-assisted management programme for antibiotics and other anti-infective agents. N Engl J Med 1998; 338: 232–8
   PubMed Web of Science ®Google Scholar
• Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124: 884–90
   PubMed Web of Science ®Google Scholar
• Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27: 355–62
   PubMed Web of Science ®Google Scholar
• Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249–56
   PubMed Web of Science ®Google Scholar
• Alvarez-Lerma F. Modification of empirical antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22: 387–94
   PubMed Web of Science ®Google Scholar
• Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196–200
   PubMed Web of Science ®Google Scholar
• Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676–85
   PubMed Web of Science ®Google Scholar
• Skoog GCO, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, et al. Point prevalence study of antibiotic use in Swedish hospitals. ECCMID. Prague. 2004
   Google Scholar
• Bailey TC, Troy McMullin S. Using information systems technology to improve antibiotic prescribing. Crit Care Med 2001; 29(Suppl 4)87–91
   Google Scholar
• Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639–44
   PubMed Web of Science ®Google Scholar
• Saeedi B, Hallgren A, Isaksson B, Jonasson J, Nilsson LE, Hanberger H. Genetic relatedness of Enterococcus faecalis isolates with high-level gentamicin resistance from patients with bacteraemia in south-east Sweden –2001. Scand J Infect Dis ;36 1994; 2004: 405–9
   Google Scholar
• Hallgren A, Saeedi B, Nilsson M, Monstein HJ, Isaksson B, Hanberger H, et al. Genetic relatedness among Enterococcus faecalis with transposon-mediated high-level gentamicin resistance in Swedish intensive care units. J Antimicrob Chemother 2003; 52: 162–7
   PubMed Web of Science ®Google Scholar